Correction: HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs (Oncogene, (2012), 31, 14, (1757-1770), 10.1038/onc.2011.365);HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs

Oncogene

Volumn 31, Issue 14, 2012, Pages 1757-1770

  Zhang, H ^a,b   Wong, C C L ^a   Wei, H ^a   Gilkes, D M ^a   Korangath, P ^a   Chaturvedi, P ^a   Schito, L ^a,c   Chen, J ^a   Krishnamachary, B ^a   Winnard Jr , P T ^a   Raman, V ^a   Zhen, L ^d   Mitzner, W A ^d   Sukumar, S ^a   Semenza, G L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

breast cancer; hypoxia; metastasis

Indexed keywords

ANGIOPOIETIN LIKE 4; DIGOXIN; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; L1 CELL ADHESION MOLECULE PROTEIN; PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG; LUNG METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; TUMOR GROWTH;

EID: 84860389759     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/s41388-020-01618-z     Document Type: Erratum

References (43)

1. Belanger AJ, Lu H, Date T, Liu LX, Vincent KA, Akita GY et al. (2002). Hypoxia up-regulates expression of peroxisome proliferator-activated receptor gamma angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor 1α. J Mol Cell Cardiol 34: 765-774. (Pubitemid 35205179)
2. Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM et al. (2003). Levels of hypoxia-inducible factor 1α independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97: 1573-1581. (Pubitemid 36297788)
3. Bos R, Zhong H, Hanrahan CF, Mommers EC, Semenza GL, Pinedo HM et al. (2001). Levels of hypoxia-inducible factor 1α during breast carcinogenesis. J Natl Cancer Inst 93: 309-314. (Pubitemid 32219818)
4. Buffa FM, Harris AL, West CM, Miller CJ. (2010). Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene. Br J Cancer 102: 428-435.
5. Cailleau R, Young R, Olivé M, Reeves Jr WJ. (1978). Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 53: 661-674.
6. Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, Kuliszewski M et al. (2000). Hypoxia-inducible factor 1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFβ3. J Clin Invest 105: 577-587. (Pubitemid 30146504)
7. Chambers AF. (2009). MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? Cancer Res 69: 5292-5293.
8. Chintala S, Tóth K, Cao S, Durrani FA, Vaughan MM, Jensen RL et al. (2010). Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1α. Cancer Chemother Pharmacol 66: 899-911.
9. Dales JP, Garcia S, Meunier-Carpentier S, Andrac-Meyer L, Haddad O, Lavaut MN et al. (2005). Overexpression of hypoxia-inducible factor HIF-1α predicts early relapse in breast cancer: retrospective study in a series of 745 patients. Int J Cancer 116: 734-739. (Pubitemid 41099705)
10. Dewhirst MW, Cao Y, Moeller B. (2008). Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer 8: 425-437. (Pubitemid 351744964)
11. Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, Koong A et al. (2009). Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15: 35-44.
12. Erler JT, Bennewith KL, Nicolau M, Dornhöfer N, Kong C, Le QT et al. (2006). Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440: 1222-1226.
13. Fukuda R, Zhang H, Kim JW, Shimoda L, Dang CV, Semenza GL. (2007). HIF-1 regulates cytochome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129: 111-122. (Pubitemid 46507584)
14. Galaup A, Cazes A, Le Jan S, Philippe J, Connault E, Le Coz E et al. (2006). Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci USA 103: 18721-18726. (Pubitemid 44913477)
15. Generali D, Berruti A, Brizzi MP, Campo L, Bonardi S, Wigfield S et al. (2006). Hypoxia-inducible factor-1α expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clin Cancer Res 12: 4562-4568. (Pubitemid 44297805)
16. Giatromanolaki A, Koukourakis MI, Simopoulos C, Polychronidis A, Gatter KC, Harris AL et al. (2004). c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-1α dependent. Clin Cancer Res 10: 7972-7977. (Pubitemid 39587538)
17. Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, Nadal C et al. (2007). Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446: 765-770. (Pubitemid 46582040)
18. Helczynska K, Larsson AM, Holmquist-Mengelbier L, Bridges E, Fredlund E, Borgquist S et al. (2008). Hypoxia-inducible factor 2α correlates to distant recurrence and poor outcome in invasive breast cancer. Cancer Res 68: 9212-9220.
19. Issa Y, Nummer D, Seibel T, Müerköster SS, Koch M, Schmitz-Winnenthal F et al. (2009). Enhanced L1CAM expression on pancreatic tumor endothelium mediates selective tumor cell transmigration. J Mol Med 87: 99-112.
20. Krishnamachary B, Zagzag D, Nagasawa H, Rainey K, Okuyama H, Baek JH et al. (2006). Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res 66: 2725-2731.
21. Kronblad A, Jirstrom K, Ryden L, Nordenskjold B, Landberg G. (2006). Hypoxia inducible factor-1α is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response. Int J Cancer 118: 2609-2016.
22. Liao D, Corle C, Seagroves TN, Johnson RS. (2007). Hypoxia-inducible factor-1α is a key regulator of metastasis in a transgenic model of cancer initiation and progression. Cancer Res 67: 563-572. (Pubitemid 46192193)
23. Liotta LA, Kohn EC. (2000) In: Bast, RC, Kufe, DW, Pollock, RE, Weichselbaum, RR, Holland, JF, Frei E(ed). Cancer Medicine. B.C. Decker: Hamilton, Canada, pp 121-131.
24. Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ et al. (2005). Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105: 659-669. (Pubitemid 40070750)
25. Melillo G. (2007). Targeting hypoxia cell signaling for cancer therapy. Cancer Metastasis Rev 26: 341-352.
26. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD et al. (2005). Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524. (Pubitemid 41112921)
27. Nishi H, Nakada T, Hokamura M, Osakabe Y, Itokazu O, Huang LE et al. (2004). Hypoxia-inducible factor-1 transactivates transforming growth factor-beta3 in trophoblast. Endocrinology 145: 4113-4118. (Pubitemid 39120559)
28. Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR et al. (2008). TGFβ primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133: 66-77. (Pubitemid 351442989)
29. Pal SK, Childs BH, Pegram M. (2011). Triple negative breast cancer: unmet medical needs. Breast Cancer Res Treat 125: 627-636.
30. Palmieri C, Krell J, James CR, Harper-Wynne C, Misra V, Cleator S et al. (2010). Rechallenging with anthacyclines and taxanes in metastatic breast cancer. Nat Rev Clin Oncol 7: 561-574.
31. Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, Gnant M et al. (2002). Overexpression of hypoxia-inducible factor 1α is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 8: 1831-1837. (Pubitemid 34633742)
32. Semenza GL. (2010). Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29: 625-634.
33. Subarsky P, Hill RP. (2003). The hypoxic tumor microenvironment and metastatic progression. Clin Exp Metastasis 20: 237-250. (Pubitemid 36513228)
34. Tafani M, Russo A, Di Vito M, Sale P, Pellegrini L, Schito L et al. (2010). Up-regulation of pro-inflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma microenvironment. Cancer Sci 101: 1014-1023.
35. Talmadge JE, Fidler IJ. (2010). AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res 70: 5649-5669.
36. Trastour C, Benizri E, Ettore F, Ramaioli A, Chamorey E, Pouyssegur J et al. (2007). HIF-1α and CA IX staining in invasive breast carcinomas: Prognosis and treatment outcome. Int J Cancer 120: 1443-1450.
37. Ueno M, Maeno T, Nomura M, Aoyagi-Ikeda K, Matsui H, Hara K et al. (2011). Hypoxia-inducible factor-1α mediates TGF-β-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 300: L740-L752.
38. Vaupel P, Mayer A, Höckel M. (2004). Tumor hypoxia and malignant progression. Meth Enzymol 381: 355-354.
39. Verheul HM, Salumbides B, Van Erp K, Hammers H, Qian DZ, Sanni T et al. (2008). Combination strategy targeting the hypoxia inducible factor-1α with mammalian target of rapamycin and histone deacetylase inhibitors. Clin Cancer Res 14: 3589-3597.
40. Vleugel MM, Greijer AE, Shvarts A, van der Groep P, van Berkel M, Aarbodem Y et al. (2005). Differential prognostic impact of hypoxia induced and diffuse HIF-1α expression in invasive breast cancer. J Clin Pathol 58: 172-177. (Pubitemid 40193803)
41. 2 tension. Proc Natl Acad Sci USA 92: 5510-5514.
42. Yamamoto Y, Ibusuki M, Okumura Y, Kawasoe T, Kai K, Ivama K et al. (2008). Hypoxia-inducible factor 1α is closely linked to an aggressive phenotype in breast cancer. Breast Cancer Res Treat 110: 465-475. (Pubitemid 351962589)
43. Zhang H, Qian DZ, Tan YS, Lee K, Gao P, Ren YR et al. (2008). Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth. Proc Natl Acad Sci USA 105: 19579-19586.